{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:29:39Z","timestamp":1776468579991,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T00:00:00Z","timestamp":1156982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2007,1,19]]},"DOI":"10.1007\/s11060-006-9229-7","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T10:24:12Z","timestamp":1156933452000},"page":"279-285","source":"Crossref","is-referenced-by-count":47,"title":["Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine"],"prefix":"10.1007","volume":"81","author":[{"given":"Anna Maria","family":"Mauro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Bomprezzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Morresi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leandro","family":"Provinciali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Formica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Iacoangeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Scerrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,8,31]]},"reference":[{"key":"9229_CR1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF01665108","volume":"57","author":"PM Foy","year":"1981","unstructured":"Foy PM, Copeland GP, Shaw MDM (1981) The natural history of postoperative seizures. Acta Neurochir 57:15\u201322","journal-title":"Acta Neurochir"},{"key":"9229_CR2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/jnnp.55.9.753","volume":"55","author":"PM Foy","year":"1992","unstructured":"Foy PM, Chadwick DW, Rajgopalan N, Johnson AL, Shaw MD (1992) Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry 55:753\u2013757","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"9229_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1528-1157.2002.24801.x","volume":"43","author":"A DeSantis","year":"2002","unstructured":"DeSantis A, Villani R, Sinisi M, Stocchetti N, Perucca E (2002) Add-on Phenytoin fails to prevent early seizures after surgery for supratentorial brain tumors: a randomized controlled study. Epilepsia 43(2):175\u2013182","journal-title":"Epilepsia"},{"key":"9229_CR4","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jnnp.67.4.474","volume":"67","author":"LFM Beenem","year":"1999","unstructured":"Beenem LFM, Lindeboom J, Kasteleijn-Nolst Trenit\u00e8 DGA, Heimans JJ, Snoek FJ, Touw DJ, Ad\u00e8r HJ, van Alphen HAM (1999) Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects. J Neurol Neurosurg Psychiatry 67:474\u2013480","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9229_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S0317167100022757","volume":"7","author":"E Matthew","year":"1980","unstructured":"Matthew E, Sherwin AL, Welner SA, Odusote K, Stratford JG (1980) Seizures following intracranial surgery: incidence in the first post-operative week. Can J Neurol Sci 7:285\u2013290","journal-title":"Can J Neurol Sci"},{"key":"9229_CR6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1059-1311(96)80023-9","volume":"5","author":"JM Kuijlen","year":"1996","unstructured":"Kuijlen JM, Teernstra OP, Kessels AG, Herpers MJ, Beuls EA (1996) Effectiveness of antiepileptic drug prophylaxis used in supratentorial craniotomies. A meta-analysis. Seizure 5:291\u2013298","journal-title":"Seizure"},{"key":"9229_CR7","first-page":"95","volume-title":"Pharmacological prophylaxis of posttraumatic epilepsy","author":"A DeSantis","year":"1991","unstructured":"DeSantis A (1991) Diffusion of antiepileptic prophylaxis in Italy. In: Murri L, Parenti G, Annegers JF (eds) Pharmacological prophylaxis of posttraumatic epilepsy. Piccin Edizioni, Padua, pp 95\u2013112"},{"key":"9229_CR8","first-page":"162","volume-title":"The treatment of epilepsy","author":"E Perucca","year":"1996","unstructured":"Perucca E (1996) Priciples of drug treatment. In: Shorvon SD, Dreifuss F, Fish D (eds) The treatment of epilepsy. Blackwell Science, Oxford, pp 162\u2013168"},{"key":"9229_CR9","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.54.10.1886","volume":"54","author":"M Glantz","year":"2000","unstructured":"Glantz M, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Neurology 54:1886\u20131893","journal-title":"Neurology"},{"key":"9229_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0090-3019(89)90067-0","volume":"31","author":"ST Lee","year":"1989","unstructured":"Lee ST, Lui TN, Chang CN, Cheng WC, Wang DJ, Heimburger RF, Lin CG (1989) Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 31:361\u2013364","journal-title":"Surg Neurol"},{"issue":"1","key":"9229_CR11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1227\/00006123-198301000-00003","volume":"12","author":"DA Kvuam","year":"1983","unstructured":"Kvuam DA, Loftus CM, Copeland B, Quest DO (1983) Seizures during the immediate postoperative period. Neurosurgery 12(1):14\u201317","journal-title":"Neurosurgery"},{"key":"9229_CR12","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/jns.1983.58.5.0672","volume":"58","author":"JB North","year":"1983","unstructured":"North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB (1983) Phenytoin and post-operative epilepsy: a double-blind study. J Neurosurg 58:672\u2013677","journal-title":"J Neurosurg"},{"issue":"4","key":"9229_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1046\/j.1535-7597.2002.00038.x","volume":"2","author":"NR Temkin","year":"2002","unstructured":"Temkin NR (2002) Prophylactic anticonvulsants after neurosurgery. Epilepsy Curr 2(4):105\u2013107","journal-title":"Epilepsy Curr"},{"key":"9229_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01420191","volume":"103","author":"S Franceschetti","year":"1990","unstructured":"Franceschetti S, Binelli S, Casazza M, Lodrini S, Panzica F, Plachino F, Solero CL, Avanzini G (1990) Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumors. Acta Neurochir 103:47\u201351","journal-title":"Acta Neurochir"},{"key":"9229_CR15","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1017\/S0317167100053361","volume":"30","author":"PA Forsyth","year":"2003","unstructured":"Forsyth PA, Weaver S, Fulton D, Brasher PM, Sutherland G, Stewart D, Hagen NA, Barnes P, Cairncross JG, DeAngelis LM (2003) Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 30:106\u2013112","journal-title":"Can J Neurol Sci"},{"issue":"4","key":"9229_CR16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/WNL.46.4.985","volume":"46","author":"MJ Glantz","year":"1996","unstructured":"Glantz MJ, Cole BF, Friedberg MH, Lathi E, Choy H, Furie K, Akerley W, Wahlberg L, Lekos A, Louis S (1996) A randomised, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 46(4):985\u2013991","journal-title":"Neurology"},{"key":"9229_CR17","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1227\/00006123-198503000-00002","volume":"16","author":"DJ Boarini","year":"1985","unstructured":"Boarini DJ, Beck DW, VanGilder JC (1985) Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 16:290\u2013292","journal-title":"Neurosurgery"},{"key":"9229_CR18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF01411737","volume":"138","author":"A Levati","year":"1996","unstructured":"Levati A, Savoia G, Zoppi F, Boselli L, Tommasino C (1996) Peri-operative prophylaxis with phenitoin: dosage and therapeutic plasma levels. Acta Neurochir 138:274\u2013278","journal-title":"Acta Neurochir"},{"key":"9229_CR19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1528-1157.2001.28900.x","volume":"42","author":"NR Temkin","year":"2001","unstructured":"Temkin NR (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42:515\u2013524","journal-title":"Epilepsia"},{"key":"9229_CR20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.4065\/79.12.1489","volume":"79","author":"JI Sirven","year":"2004","unstructured":"Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS (2004) Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc 79:1489\u20131494","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"9229_CR21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1517\/13543784.8.7.1103","volume":"8","author":"SC Schachter","year":"1999","unstructured":"Schachter SC (1999) Oxcarbazepine: current status and clinical applications. Exp Opin Invest Drugs 8(7):1103\u20131112","journal-title":"Exp Opin Invest Drugs"},{"key":"9229_CR22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/ebeh.2000.0126","volume":"1","author":"D Schmidt","year":"2000","unstructured":"Schmidt D, Sachdeo R (2000) Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy Behav 1:396\u2013405","journal-title":"Epilepsy Behav"},{"issue":"2","key":"9229_CR23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00023210-200115020-00005","volume":"15","author":"K Wellington","year":"2001","unstructured":"Wellington K, Goa KL (2001) Oxcarbazepine: an update of its efficacy in management of epilepsy. CNS Drugs 15(2):137\u2013163","journal-title":"CNS Drugs"},{"key":"9229_CR24","unstructured":"Kleihues P, Cavanee WK (eds) (2000) World Health Organization classification of tumors. Pathology and genetics: tumors of the Nervous system. IARC press, Lyon"},{"key":"9229_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1528-1157.1987.tb03633.x","volume":"28","author":"EH Reynolds","year":"1983","unstructured":"Reynolds EH (1983) Early treatment and prognosis of epilepsy. Epilepsia 28:97\u2013106","journal-title":"Epilepsia"},{"issue":"6 suppl 19","key":"9229_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.seminoncol.2003.11.030","volume":"30","author":"CJ Vecht","year":"2003","unstructured":"Vecht CJ, Wagner GL, Wilms EB (2003) Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Sem Oncol 30(6 suppl 19):49\u201352","journal-title":"Sem Oncol"},{"key":"9229_CR27","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","volume":"2","author":"CJ Vecht","year":"2003","unstructured":"Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2:404\u2013409","journal-title":"Lancet Neurol"},{"key":"9229_CR28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72:255\u2013260","journal-title":"J Neurooncol"},{"issue":"1","key":"9229_CR29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1517\/14656566.3.1.59","volume":"3","author":"A Beydoun","year":"2001","unstructured":"Beydoun A, Kutluay E (2001) Oxcarbazepine. Expert Opin Pharmacother 3(1):59\u201371","journal-title":"Expert Opin Pharmacother"},{"issue":"suppl 5","key":"9229_CR30","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1528-1157.1999.tb00918.x","volume":"40","author":"ES Tecoma","year":"1999","unstructured":"Tecoma ES (1999) Oxcarbazepine. Epilepsia 40(suppl 5):S37-S46","journal-title":"Epilepsia"},{"key":"9229_CR31","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00003495-199243060-00007","volume":"43","author":"SM Grant","year":"1992","unstructured":"Grant SM, Faulds D (1992) Oxcarbazepine: a review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders. Drugs 43:873\u2013888","journal-title":"Drugs"},{"issue":"suppl 3","key":"9229_CR32","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.1994.tb05938.x","volume":"35","author":"P Lloyd","year":"1994","unstructured":"Lloyd P, Flesch G, Dieterle W (1994) Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 35(suppl 3):S10\u2013S13","journal-title":"Epilepsia"},{"issue":"suppl 9","key":"9229_CR33","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1528-1157.1999.tb02088.x","volume":"40","author":"E Perucca","year":"1999","unstructured":"Perucca E (1999) The clinical pharmacokinetics of the new antiepileptic drugs. Epilepsia 40(suppl 9):S7\u2013S13","journal-title":"Epilepsia"},{"key":"9229_CR34","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3109\/00498258609043567","volume":"16","author":"H Schutz","year":"1986","unstructured":"Schutz H, Feldman KF, Faigle JW, Kriemler HP, Winkler T (1986) The metabolism of 14C-oxcarbazepine in man. Xenobiotica 16:769\u2013778","journal-title":"Xenobiotica"},{"key":"9229_CR35","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1099-081X(199701)18:1<17::AID-BDD997>3.0.CO;2-R","volume":"18","author":"H Jung","year":"1997","unstructured":"Jung H, Noguez A, Mayet L, Fuentes I, Gonzales-Esquivel DF (1997) The distribution of 10-hydroxycarbazepine in blood compartments. Biopharm Drug Disposit 18:17\u201323","journal-title":"Biopharm Drug Disposit"},{"issue":"2","key":"9229_CR36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0188-4409(00)00056-4","volume":"31","author":"DF Gonzalez-Esquivel","year":"2000","unstructured":"Gonzalez-Esquivel DF, Ortega-Gavilan M, Alcantara-Lopez G, Jung-Cook H (2000) Plasma level monitoring of oxcarbazepine in epileptic patients. Arch Med Res 31(2):202\u2013205","journal-title":"Arch Med Res"},{"key":"9229_CR37","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM199008233230801","volume":"323","author":"NR Temkin","year":"1990","unstructured":"Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR (1990) A randomised, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 323:497\u2013502","journal-title":"N Engl J Med"},{"issue":"suppl 3","key":"9229_CR38","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1528-1157.1994.tb05939.x","volume":"35","author":"A Baruzzi","year":"1994","unstructured":"Baruzzi A, Albani F, Riva R (1994) Oxcarbazepine: pharmacokinetic interactions and their clinical relevance. Epilepsia 35(suppl 3):S14\u2013S19","journal-title":"Epilepsia"},{"key":"9229_CR39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2125.1991.tb03858.x","volume":"31","author":"JG Larkin","year":"1991","unstructured":"Larkin JG, Mckee PJ, Forrest G, Beastall GH, Park BK, Lowrie JI, Lloyd P, Brodie MJ (1991) Lack of enzyme induction with oxcarbazepine (600\u00a0mg daily) in healthy subjects. Br J Clin Pharmacol 31:65\u201371","journal-title":"Br J Clin Pharmacol"},{"key":"9229_CR40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/ana.10190","volume":"51","author":"RC Sachdeo","year":"2002","unstructured":"Sachdeo RC, Wasserstein A, Mesenbrik PJ, D\u2019Souza J (2002) Effect of oxcarbazepine on sodium concentration and water handling. Ann Neurol 51:613\u2013620","journal-title":"Ann Neurol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-006-9229-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-006-9229-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-006-9229-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:18:58Z","timestamp":1559348338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-006-9229-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,31]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,1,19]]}},"alternative-id":["9229"],"URL":"https:\/\/doi.org\/10.1007\/s11060-006-9229-7","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,31]]}}}